» Authors » Stefano Severi

Stefano Severi

Explore the profile of Stefano Severi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 133
Citations 2055
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Grassi I, Nicolini S, Marini I, Matteucci F, Ranallo N, Di Iorio V, et al.
Neuroendocrinology . 2024 Nov; :1-12. PMID: 39571544
Introduction: Lu-PRRT in neuroendocrine tumors is usually delivered with a total cumulative activity (TCA) of 29.6 GBq, divided into 4 cycles and with fixed interval between cycles (IBCs) of 8...
2.
Bartolucci C, Mesirca P, Ricci E, Sales-Belles C, Torre E, Louradour J, et al.
J Physiol . 2024 Sep; 602(19):4821-4847. PMID: 39269369
The atrioventricular node (AVN) is a crucial component of the cardiac conduction system. Despite its pivotal role in regulating the transmission of electrical signals between atria and ventricles, a comprehensive...
3.
Severi S, Grassi I, Bongiovanni A, Nicolini S, Marini I, Arpa D, et al.
J Nucl Med . 2024 Aug; 65(9):1409-1415. PMID: 39142827
Recurrence of meningiomas after surgery and radiotherapy deserves specific attention because of the lack of active third-line therapies. Somatostatin receptors are usually overexpressed on the cell membrane of meningiomas, and...
4.
Ricci E, Mazhar F, Marzolla M, Severi S, Bartolucci C
Front Physiol . 2024 Aug; 15:1408626. PMID: 39139481
Cardiac pacemaking remains an unsolved matter from many perspectives. Extensive experimental and computational studies have been performed to describe the sinoatrial physiology across different scales, from the molecular to clinical...
5.
Botti S, Bartolucci C, Altomare C, Paci M, Barile L, Krause R, et al.
Comput Biol Med . 2024 Aug; 180:108899. PMID: 39106668
This work introduces the first atrial-specific in-silico human induced pluripotent stem cells-derived cardiomyocytes (hiPSC-CMs) model, based on a set of phenotype-specific I,I and I membrane currents. This model is built...
6.
Bongiovanni A, Liverani C, Foca F, Bergamo F, Leo S, Pusceddu S, et al.
Eur J Cancer . 2024 Jul; 208:114129. PMID: 39002347
Background: Neuroendocrine Carcinomas (NECs) prognosis is poor.No standard second-line therapy is currently recognized after failure of platinum-based first-line treatment. FOLFIRI and CAPTEM regimens have shown promising activity in preliminary studies....
7.
Mazhar F, Bartolucci C, Regazzoni F, Paci M, Dede L, Quarteroni A, et al.
Vascul Pharmacol . 2024 Jul; 155:107330. PMID: 38985637
No abstract available.
8.
Ricci E, Bartolucci C, Marzolla M, Severi S
Vascul Pharmacol . 2024 Jul; 155:107344. PMID: 38985622
No abstract available.
9.
Molla D, Frosio A, Bertoli G, Piantoni C, Arici M, Bartolucci C, et al.
Vascul Pharmacol . 2024 Jul; 155:107337. PMID: 38985615
No abstract available.
10.
Benzoni P, Gazzerro E, Fiorillo C, Baratto S, Bartolucci C, Severi S, et al.
Int J Mol Sci . 2024 Jan; 25(2). PMID: 38256054
Caveolae constitute membrane microdomains where receptors and ion channels functionally interact. Caveolin-3 (cav-3) is the key structural component of muscular caveolae. Mutations in lead to caveolinopathies, which result in both...